1. Home
  2. BYND vs ELDN Comparison

BYND vs ELDN Comparison

Compare BYND & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • ELDN
  • Stock Information
  • Founded
  • BYND 2009
  • ELDN 2004
  • Country
  • BYND United States
  • ELDN United States
  • Employees
  • BYND N/A
  • ELDN N/A
  • Industry
  • BYND Packaged Foods
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • ELDN Health Care
  • Exchange
  • BYND Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • BYND 296.7M
  • ELDN 288.5M
  • IPO Year
  • BYND 2019
  • ELDN N/A
  • Fundamental
  • Price
  • BYND $4.00
  • ELDN $4.09
  • Analyst Decision
  • BYND Sell
  • ELDN Strong Buy
  • Analyst Count
  • BYND 6
  • ELDN 1
  • Target Price
  • BYND $5.50
  • ELDN $16.00
  • AVG Volume (30 Days)
  • BYND 4.1M
  • ELDN 520.7K
  • Earning Date
  • BYND 02-25-2025
  • ELDN 11-12-2024
  • Dividend Yield
  • BYND N/A
  • ELDN N/A
  • EPS Growth
  • BYND N/A
  • ELDN N/A
  • EPS
  • BYND N/A
  • ELDN N/A
  • Revenue
  • BYND $323,473,000.00
  • ELDN N/A
  • Revenue This Year
  • BYND N/A
  • ELDN N/A
  • Revenue Next Year
  • BYND $3.70
  • ELDN N/A
  • P/E Ratio
  • BYND N/A
  • ELDN N/A
  • Revenue Growth
  • BYND N/A
  • ELDN N/A
  • 52 Week Low
  • BYND $3.30
  • ELDN $1.52
  • 52 Week High
  • BYND $12.12
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • BYND 49.41
  • ELDN 47.03
  • Support Level
  • BYND $3.50
  • ELDN $3.68
  • Resistance Level
  • BYND $4.22
  • ELDN $4.19
  • Average True Range (ATR)
  • BYND 0.25
  • ELDN 0.32
  • MACD
  • BYND 0.09
  • ELDN -0.04
  • Stochastic Oscillator
  • BYND 72.15
  • ELDN 31.54

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: